Baker Brothers Advisors - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$2,310,000
-29.7%
57,1400.0%0.02%
-27.6%
Q2 2015$3,288,000
-9.6%
57,1400.0%0.03%
-3.3%
Q1 2015$3,638,000
-38.8%
57,140
-40.7%
0.03%
-50.8%
Q4 2014$5,946,000
+59.0%
96,3030.0%0.06%
+29.8%
Q3 2014$3,739,000
+12.7%
96,3030.0%0.05%
+14.6%
Q2 2014$3,318,000
-20.3%
96,3030.0%0.04%
-22.6%
Q1 2014$4,161,000
-57.7%
96,303
-61.0%
0.05%
-61.9%
Q4 2013$9,842,000
+6.1%
247,0360.0%0.14%
+5.3%
Q3 2013$9,274,000
+39.7%
247,0360.0%0.13%
+0.8%
Q2 2013$6,638,000247,0360.13%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q2 2013.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders